跳至主要内容
临床试验/NCT01680107
NCT01680107终止3 期

The Effect of a Single-dose of D-cycloserine on the Basic Effects of Cognitive-behaviour Therapy for Panic Disorder - a Randomized Placebo-controlled Trial

University of Oxford1 个研究点 分布在 1 个国家目标入组 33 人开始时间: 2012年10月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
3 期
状态
终止
入组人数
33
试验地点
1
主要终点
self-reported and clinician-rated anxiety and depression measures

研究概览

简要总结

The purpose of this study is to determine whether d-cycloserine augments the clinical effects of exposure-based cognitive-behaviour therapy for panic disorder.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Basic Science
盲法
Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)

入排标准

年龄范围
18 Years 至 65 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • clinical diagnosis of panic disorder
  • at least moderate agoraphobic avoidance

排除标准

  • psychoactive medication last 6 weeks
  • exposure-based cognitive-behaviour treatment for panic disorder and agoraphobia during last 3 months
  • female participant who is pregnant or breast-feeding
  • lifetime history of psychosis, bipolar disorder, alcohol, medication or drug abuse or dependence; current primary depressive disorder
  • lifetime history of epilepsy or other significant disease or disorder

研究组 & 干预措施

d-cycloserine

Experimental

oral, capsule, 250 mg, once

干预措施: d-cycloserine (Drug)

d-cycloserine

Experimental

oral, capsule, 250 mg, once

干预措施: cognitive-behaviour therapy (Behavioral)

sugar pill

Placebo Comparator

oral, capsule, once

干预措施: placebo (Drug)

sugar pill

Placebo Comparator

oral, capsule, once

干预措施: cognitive-behaviour therapy (Behavioral)

结局指标

主要结局

self-reported and clinician-rated anxiety and depression measures

时间窗: 6 months

次要结局

  • emotional information processing(1 day)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验